Head and neck cancer is the eighth most common malignancy and numbers are increasing. This has led to increasing number of suspected cancer referrals which, with imposition of the 28-day Faster Diagnosis Standard implemented in 2020, has further burdened the...
2 July 2025
| Camilla Dawson, Mary Elizabeth Quinn, Paul Pracy
|
ENTA - Head & Neck
Treatment for H&N cancer can be extremely tough for patients. How do we explain the likely impact as they try to make decisions? And what happens when they regret their choice? Treatment regret is a form of decision regret, involving...
4 September 2025
| Anjali Chander, Miguel Reis Ferreira
|
ENTA - Head & Neck
Oral microbiota, especially Fusobacterium nucleatum, may improve survival and guide personalised treatment in head and neck squamous cell carcinoma. Head and neck squamous cell carcinoma (HNSCC) is a devastating disease with a low five-year survival rate that has shown little...
C2Dx Inc., a medical device company based in the U.S., has acquired the otolaryngology/head and neck surgery (“OHNS”) family of products from Cook Medical.
Currently, radiotherapy and chemotherapy is the most common modality used in the management of primary head and neck squamous cell carcinomas (HNSCC). Unfortunately, around 50% of patients experience disease recurrence (rHNSCC). Surgery is therefore often used as a salvage treatment....
In the first article of this History of ENT edition, Albert Mudry explains why history is so intrinsically relevant to the practice of medicine and tells us how to use history as a foundation for the discovery of new ideas,...
Sir Felix Semon was an outstanding clinician and exceptional laryngologist. The money raised by donations from his colleagues on his retirement in 1909 was used to establish the London University’s Semon Lecture. Semon’s Obituary in the BMJ, reads: “In Semon's...
Technology and innovation has provided modern head and neck surgeons with successive generations of robotic surgical systems, fibre-optic lasers, and novel tools which have ushered in a new era of minimally invasive surgery for tumours of the pharynx and larynx....
3 March 2021
| Rolvix H Patterson, Blake C Alkire, Deepak Yadav
|
ENTA - Head & Neck
More than 500,000 people across the globe will die this year from head and neck cancer, which is the sixth most common cancer in the world and comprises malignancies of the nose, mouth, throat, larynx, and neck. Assuming current trends...
A decade of innovation in digital, remote endoscopy is paving the way for ‘drop-in’ nasendoscopy, improving early head and neck cancer diagnosis in high-risk communities. In May 2026, the University Hospitals North Midlands (UHNM) will inaugurate its newly established clinical...
If there’s one thing I love about a book review, it’s the unique opportunity to handle, peruse and imbibe a piece of work before it reaches the masses. There are few things more enjoyable than engaging with printer-fresh pages and...